Artificial Intelligence in Healthcare Market Report 2026

The artificial intelligence in healthcare market size has grown exponentially in recent years. It will grow from $24.1 billion in 2025 to $31.97 billion in 2026 at a compound annual growth rate (CAGR) of 32.6%. The growth in the historic period can be attributed to rising healthcare data volumes, shortage of skilled healthcare professionals, adoption of electronic health records, growing need for early disease detection, advancements in medical imaging technologies.

The artificial intelligence in healthcare market size is expected to see exponential growth in the next few years. It will grow to $91.85 billion in 2030 at a compound annual growth rate (CAGR) of 30.2%. The growth in the forecast period can be attributed to growth of precision medicine initiatives, increasing adoption of AI in diagnostics, demand for personalized treatment plans, expansion of remote patient monitoring, rising healthcare cost optimization efforts. Major trends in the forecast period include AI powered medical imaging, predictive analytics for patient outcomes, virtual health assistants, AI driven drug discovery, clinical decision support systems.

Increasing government initiatives to support artificial intelligence in healthcare are expected to drive growth in the AI in healthcare market. Government initiatives refer to targeted programs or actions by public authorities to address national priorities, support development, and promote strategic goals. Such initiatives are rising due to rapid technological, economic, and social changes that require proactive public intervention to ensure stable growth and address emerging challenges. These initiatives advance AI in healthcare by providing funding and clear policy guidance, enabling faster development and wider adoption of AI technologies that improve diagnosis, treatment, and patient care. For instance, in June 2024, according to the Department of Health and Aged Care, an Australia-based government agency, the Albanese Government committed nearly $30 million to research exploring innovative applications of AI to enhance access to healthcare services and maintain a world-class health system. Therefore, increasing government initiatives are promoting growth in the AI in healthcare market.

Major companies in the AI in healthcare market are focusing on innovative solutions such as AI-powered electronic health records (EHRs) to enhance clinical decision-making, streamline administrative workflows, improve patient outcomes, and enable more personalized and efficient healthcare delivery. AI-powered EHRs are digital health record systems that integrate AI technologies to improve the management, analysis, and utilization of patient data. For instance, in August 2025, Oracle, a US-based technology corporation, launched its next-generation AI-powered EHR system, combining machine learning algorithms with a user-friendly interface. The platform automates administrative tasks, predicts patient risks, recommends personalized treatments, and facilitates real-time clinical decision-making, reducing clinician burnout and enhancing operational efficiency. This solution is applicable across hospitals, clinics, and telehealth platforms seeking advanced AI integration in patient care management.

In September 2024, Stryker Corporation, a U.S.-based medical technology firm, announced its acquisition of care.AI for an undisclosed sum. This acquisition is intended to strengthen Stryker's digital healthcare strategy by incorporating advanced AI-assisted virtual care solutions into its offerings. By enhancing its expertise in smart room technology and ambient intelligence, Stryker aims to improve real-time decision-making tools that assist healthcare providers and enhance patient care outcomes. Care.AI is a U.S.-based company that specializes in artificial intelligence-driven healthcare solutions.

Major companies operating in the artificial intelligence in healthcare market are IBM Watson Health; Nuance Communications, Inc; Alphabet Inc; Concreto HealthAI; Nvidia Corporation; PathAI; XtalPi; Benevolent AI; Exscientia; OWKIN; LiveHealth; ChironX; Consure Medical; Predible Health; Lybrate; Artelus; OncoStem Qure.ai; Jiaxing Taimei Medical Technology; Ping An Health Medical Technology; YITU; iCarbonX; Insilico; Skin Analytics; Babylon Health; Cambridge Cognition; Renalytix AI; Iktos; Novartis; Gero; Ardigen; Botkin; Webiomed; Care Mentor AI; Diagnocat; Atomwise Inc; Cloud Pharmaceuticals; Bioage; NuMedii; Envisagenics; Aria Pharmaceuticals; Verge Genomics; Berg LLC; Deep Genomics; Cyclica; IQVIA; Roche; Pfizer; PRA Healthscience; Gesto; Intensicare; Didoc; Betterfly; Deenty; Examedi; Dentalink; Cero; MedPass; Pixeon; Hi Technologies; Conexa Saude; Wuru; Yerbo; BioScience; Caecus; Epitrack; GE Healthcare; Oncora Medical; Recursion Pharmaceuticals Inc; Nucleai; Pepticom; AstraZeneca; Rology; HearX Group; DilenyTech; iNNOHEALTH Technology Solutions.

North America was the largest region in the Artificial Intelligence in the Healthcare market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial intelligence in healthcare market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the artificial intelligence in healthcare market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs have influenced the artificial intelligence in healthcare market by increasing costs of imported AI enabled medical devices, imaging systems, sensors, and computing hardware. These cost pressures have affected hospitals and diagnostic centers, especially in regions dependent on imported healthcare technology such as asia pacific. Higher equipment costs have slowed adoption of advanced AI driven diagnostic tools. Healthcare providers are increasingly prioritizing software centric AI solutions and cloud based analytics platforms. In the long term, tariffs have supported local manufacturing of medical devices and strengthened regional health technology innovation ecosystems.

The artificial intelligence in healthcare market research report is one of a series of new reports that provides artificial intelligence in healthcare market statistics, including artificial intelligence in healthcare industry global market size, regional shares, competitors with a artificial intelligence in healthcare market share, detailed artificial intelligence in healthcare market segments, market trends and opportunities, and any further data you may need to thrive in the artificial intelligence in healthcare industry. This artificial intelligence in healthcare market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

AI in healthcare denotes the utilization of machine learning and cognitive algorithms to enhance treatment methods and patient outcomes. It finds application across various healthcare facets such as medical diagnostics, drug discovery, clinical trials, pain management, and overall patient improvement.

AI in healthcare offerings primarily comprises hardware and software. Within these offerings, AI products leverage diverse algorithms including deep learning, querying methods, natural language processing, and context-aware processing. Medical device manufacturers harness AI-based technologies to innovate hardware products, aiding healthcare providers and enhancing treatments. Technology firms focus on developing AI algorithms tailored for healthcare solutions. The applications of AI in healthcare are widespread, encompassing robot-assisted surgery, virtual nursing aides, support in administrative workflows, fraud detection, dosage error reduction, identification of clinical trial participants, and preliminary diagnoses. Key users of AI in healthcare span hospitals, diagnostic centers, pharmaceutical and biopharmaceutical companies, healthcare payers, and individual patients.

The AI in healthcare market includes revenues earned by entities by discovering links between genetic codes, powering surgical robots and maximizing hospital efficiency. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.